Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» FGF19 aldafermin
FGF19 aldafermin
Early readout from small NGM study shows NASH drug hits liver fat, but shares fall
Fierce Biotech
Mon, 10/7/19 - 11:05 am
NGM Biopharmaceuticals
NASH
clinical trials
FGF19 aldafermin